Apple held a press conference today. They announced a watch that can cost over $10,000 if you’re feeling saucy. A gold laptop if you’re feeling Midas-y. And an extension of HealthKit called ResearchKit, which is why we’ve gathered here today.
ResearchKit is “an open source software framework that makes it easy for researchers and developers to create apps that could revolutionize medical studies, potentially transforming medicine forever.” You can learn more about it here. At its launch, ResearchKit includes a rollout of five (5) apps: one for asthma, parkinson’s disease, diabetes, breast cancer, and cardiovascular disease. Again, you can learn more about each of their apps on their ResearchKit landing page.
Of course, this isn’t the first time diabetes shared the spotlight of Apple’s grand stage, remember the iBGStar? But seeing diabetes get an early adoption along with four other prominent diseases is a big deal. The fact that major hospitals and research institutions are part of this collaboration is a big deal. All of this is a very big deal. There’s a genuine opportunity to significantly impact health outcomes if widespread adoption takes off. But, the adoption must be widespread.
Over the weekend Dayle and I watched the epic hockey matchup between the United States and Russia from Sochi. Being on the west coast, and lacking most of the other NBC-based channels that are showing the winter games, our options for Olympic consumption is quite limited.
I’m sure some of you are saying “but Chris, you can watch everything online at nbcolympics.com”. And you’re right, person talking to their computer monitor, but did you know you have to verify your television service before accessing more than 30 minutes of footage? This is perfect for cord cutters because…no, wait, it isn’t perfect. Thankfully my parents have been generous with their FiOS account, allowing access to HBO Go and now full replays of Olympic events. It’s a crappy workaround, but at least it works.
The happy ending to all of this, besides the final score of the game is that we were able to watch all of this on our television thanks to some nifty connectivity between my MacBook Air and an Apple TV. Now I know making fun of Apple for one reason or another is still a thing people do, but in this case I can’t complain. It simply works. And it’s great.
I’m not sure if there’s a diabetes tie-in to this, but I’m sure I could string out some kind of connection to device connectivity and data interoperability if I really tried. Luckily, I won’t bore you with that drawn out attempt.
Sometimes I forget to post something and “secretly” adjust the timestamps so it looks like I maintain my during-the-week post schedule. I’m not going to do that with this one.
This post is being composed on a MacBook Air.
It’s been another one of those weeks. Everyone on my Xbox Friends List is playing Mass Effect 2 and everyone else is talking about Steve Jobs. These are the weeks that are particularly trying on my ability to select a topic interesting enough for both you and me. I have no right discussing a sequel to a game I have installed on my Xbox’s hard drive but have yet to play. One day that game will be a mark of pride instead of a badge of shame, but that day is not today. So let’s talk about Apple. If you missed the news — and I know you didn’t — Steve Jobs unveiled his latest masterpiece to the public on Wednesday: the iPad. As expected, everyone has an opinion on the viability and prospects of this device. Is it worth the money? Will it cure Juvenile Diabetes? Who was responsible for naming this thing? Given the circumstances, I could not resist the opportunity to gather my thoughts for you to consider and most likely dispute. But let’s not jump to conclusions just yet.
Be sure to stick around until the end for One More Thing.
On the last episode of the Post Game Report, we discussed the possibility of Apple entering the console market. As if gamers need another device taking up space on their surge protectors, sounds like a winner to me. Since sarcasm is hard to detect in written form, you’ll have to take my word for it: I am not a believer. However I do not think I was able to clearly articulate my point in the discussion. Be it nerves (I’m still new at this talking into a microphone thing), sloth (we finished recording around 12:30am EST), or maybe I just wasn’t thinking clearly enough to put together a coherent argument. Whatever the reason, it matters not, for now I am in my comfort zone. Continue reading